Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.
van Dijk N, Gil-Jimenez A, Silina K, Hendricksen K, Smit LA, de Feijter JM, van Montfoort ML, van Rooijen C, Peters D, Broeks A, van der Poel HG, Bruining A, Lubeck Y, Sikorska K, Boellaard TN, Kvistborg P, Vis DJ, Hooijberg E, Schumacher TN, van den Broek M, Wessels LFA, Blank CU, van Rhijn BW, van der Heijden MS. van Dijk N, et al. Among authors: boellaard tn. Nat Med. 2020 Dec;26(12):1839-1844. doi: 10.1038/s41591-020-1085-z. Epub 2020 Oct 12. Nat Med. 2020. PMID: 33046870 Clinical Trial.
Individual risk prediction of urinary incontinence after prostatectomy and impact on treatment choice in patients with localized prostate cancer.
Tillier CN, Vromans RD, Boekhout AH, Veerman H, Wollersheim BM, van Muilekom HAM, Boellaard TN, van Leeuwen PJ, van de Poll-Franse LV, van der Poel HG. Tillier CN, et al. Among authors: boellaard tn. Neurourol Urodyn. 2021 Aug;40(6):1550-1558. doi: 10.1002/nau.24703. Epub 2021 May 18. Neurourol Urodyn. 2021. PMID: 34004044
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
Meijer D, van Leeuwen PJ, Donswijk ML, Boellaard TN, Schoots IG, van der Poel HG, Hendrikse HN, Oprea-Lager DE, Vis AN. Meijer D, et al. Among authors: boellaard tn. BJU Int. 2022 Jan;129(1):54-62. doi: 10.1111/bju.15492. Epub 2021 Jun 16. BJU Int. 2022. PMID: 34028165 Free PMC article.
The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.
Veerman H, Donswijk M, Bekers E, Olde Heuvel J, Bodar YJL, Boellaard TN, van Montfoort ML, van Moorselaar RJA, Oprea-Lager DE, van Leeuwen PJ, Vis AN, van der Poel HG. Veerman H, et al. Among authors: boellaard tn. BJU Int. 2022 Mar;129(3):314-317. doi: 10.1111/bju.15664. Epub 2021 Dec 13. BJU Int. 2022. PMID: 34854204 Free PMC article. No abstract available.
Value of Different Magnetic Resonance Imaging-based Measurements of Anatomical Structures on Preoperative Prostate Imaging in Predicting Urinary Continence After Radical Prostatectomy in Men with Prostate Cancer: A Systematic Review and Meta-analysis.
van Dijk-de Haan MC, Boellaard TN, Tissier R, Heijmink SWTPJ, van Leeuwen PJ, van der Poel HG, Schoots IG. van Dijk-de Haan MC, et al. Among authors: boellaard tn. Eur Urol Focus. 2022 Sep;8(5):1211-1225. doi: 10.1016/j.euf.2022.01.015. Epub 2022 Feb 15. Eur Urol Focus. 2022. PMID: 35181284 Review.
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
Einerhand SMH, van Dijk N, van Dorp J, de Feijter JM, van Montfoort ML, van de Kamp MW, Schaake EE, Boellaard TN, Hendricksen K, van der Heijden MS, van Rhijn BWG. Einerhand SMH, et al. Among authors: boellaard tn. Int J Cancer. 2022 Dec 1;151(11):2004-2011. doi: 10.1002/ijc.34125. Epub 2022 Jun 10. Int J Cancer. 2022. PMID: 35603905 Free article. Clinical Trial.
An Magnetic Resonance Imaging-directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: "Less Is More".
Hagens MJ, Noordzij MA, Mazel JW, Jager A, Boellaard TN, Tielbeek JAW, Henebiens M, Schoots IG, van Leeuwen PJ, van der Poel HG, Rynja SP. Hagens MJ, et al. Among authors: boellaard tn. Eur Urol Open Sci. 2022 Aug 2;43:68-73. doi: 10.1016/j.euros.2022.07.006. eCollection 2022 Sep. Eur Urol Open Sci. 2022. PMID: 36353069 Free PMC article.
49 results